The customer observed falsely elevated alinity i free t4 results for three patients.The following data was provided (normal reference range 0.6-1.8 ng/dl): (b)(6) 2024 sid (b)(6) initial result 2.6 ng/dl, repeated 1.2 / 0.91 / 1.86 / 0.96 / 1.95 ng/dl (b)(6) 2024 sid unk initial result 2.09 ng/dl, repeated 1.02 ng/dl.(b)(6) 2024 sid (b)(6) initial result >5 ng/dl, repeated 1.0 ng/dl.(b)(6) 2024 sid (b)(6) initial result 2.45 ng/dl, repeat on another analyzer resulted 1.62 ng/dl, (b)(6) 2024 sid (b)(6) initial result 2.23 ng/dl, repeat 1.37 ng/dl.No impact to patient management was reported.
|
A review of customer data aligned with customer¿s issue and no additional issues were identified.An increase in complaints has been observed for lot 53312ud04, however, in-house performance testing was completed which indicates the product is performing as expected.Device history review did not identify any non-conformances or deviations with the list number and complaint issue.In-house performance testing was completed which indicates the product is performing as expected.Labeling was reviewed which adequately addresses the current issue.Based on the investigation, no systemic issue or deficiency of the alinity i free t4 assay was identified.
|